NEWS

Dive deeper into the world of compounds and reagents in our news and blog posts.

August 15, 2022
In the last years, and especially during the SARS-Co-2 pandemic, giant efforts were devoted to designing, synthesising and studying antiviral agents. On the other hand, too little consideration was given ...
author foto
Krystof Sigut
April 5, 2022
When a thousand people worldwide suffered from lethal coronavirus (COVID-19) in 2020, we came up with an ambitious project to contribute to the worldwide pandemic solution.Everything started with the question: ...
author foto
Krystof Sigut
February 3, 2022
Viruses are causing many troubles in our lives these days. They cause many serious diseases (some of them even deadly) such as cold, influenza, EBOLA, AIDS or COVID-19.At Santiago ...
author foto
Krystof Sigut
December 13, 2021
Viruses are pathogens occurring all around us that can be fought with antiviral drugs. Viruses are the cause of a large number of diseases, many of which are deadly – from ...
author foto
Krystof Sigut
November 19, 2021
[vc_row][vc_column][vc_column_text] Molnupiravir is a new potential drug against the SARS-CoV-2 infectious virus.   To this date, all medications against SARS-CoV-2 are administered only by infusion ...
author foto
Krystof Sigut
October 11, 2021
During the course of the last decades, outstanding efforts were devoted to design and develop nucleotide prodrugs to be employed as potential therapeutic agents, especially for the treatment of human ...
author foto
Alessandro Panattoni

LinkedIn

Contact
Kryštof

Get in touch

Krystof Sigut, CEO and Founder

Partners & distributors

logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner

Welcome to
SigutLabs

We have grown from a tiny lab to a reputable partner of global pharmaceutical leaders, scientific institutes, and biotechnology giants. Our team is composed of PhDs experts eager to help you succeed through high-end expertise combined with cost-effective reliability.

More about us
Sigut
welcome to sigutlabs
welcome to sigutlabs